BETA
This is a historical view (2014/02/06)

Changes: 2023/08/03docs, events, links.National_parliaments.url, 2021/12/18docs.docs.url, procedure.Other_legal_basis, events, events.type, procedure.Modified_legal_basis, docs, 2020/04/01docs.docs.url, events, events.docs.url, committees, procedure.stage_reached, procedure.Modified_legal_basis, committees.rapporteur, 2020/01/05events.docs.url, docs.body, 2019/08/07committees, 2019/07/06events, procedure.dossier_of_the_committee, procedure.Mandatory_consultation_of_other_institutions, procedure.summary, other, procedure.subject, commission, docs, procedure.instrument, otherinst, activities, procedure.Modified_legal_basis, committees, procedure.other_consulted_institutions, council, 2017/03/19other.dg, activities.commission.DG, 2017/03/15procedure.Mandatory_consultation_of_other_institutions, 2017/01/28other.dg, activities.commission.DG, 2016/12/22activities, 2016/07/07activities.type, 2015/11/04activities.docs.celexid, 2015/10/21activities, 2015/06/04activities.docs.celexid, 2015/06/01activities.docs.celexid, 2015/05/30activities.docs.celexid, 2015/05/27links.European_Commission.title, 2014/09/30activities, 2014/08/27activities.committees.shadows.mepref, committees.rapporteur.mepref, activities.committees.rapporteur.mepref, committees.shadows.mepref, 2014/08/08activities.type, activities.docs, 2014/07/27committees.shadows.group, activities.committees.shadows.group, 2014/07/26committees.shadows.group, activities.committees.shadows.group, 2014/07/25committees.shadows.group, activities.committees.shadows.group, 2014/07/24committees.shadows.group, activities.committees.shadows.group, 2014/07/23committees.shadows.group, activities.committees.shadows.group, 2014/07/22committees.shadows.group, activities.committees.shadows.group, 2014/07/21committees.shadows.group, activities.committees.shadows.group, 2014/07/21committees.shadows.group, activities.committees.shadows.group, 2014/07/20committees.shadows.group, activities.committees.shadows.group, 2014/07/19committees.shadows.group, activities.committees.shadows.group, 2014/07/18committees.shadows.group, activities.committees.shadows.group, 2014/07/17committees.shadows.group, activities.committees.shadows.group, 2014/07/16committees.shadows.group, activities.committees.shadows.group, 2014/07/15activities.committees.shadows, activities.committees.rapporteur, activities.committees.date, committees.shadows, committees.date, committees.rapporteur, 2014/07/07activities.committees.shadows, activities, activities.committees.rapporteur, activities.committees.date, procedure.Modified_legal_basis, committees.shadows, committees.date, committees.rapporteur, 2014/05/14activities.docs.text, 2014/05/04activities.docs.url, 2014/04/25procedure.stage_reached, activities, 2014/04/21activities.commission, activities, activities.docs, activities.type, activities.body, activities.date

View current state | View Changes for this date

Sorry, but we failed to recreate history before 2014-04-15T04:06:42

Awaiting Parliament 1st reading / single reading / budget 1st stage



2013/0305(COD) New psychoactive substances
Next event: Vote in plenary scheduled 2014/04/17 more...
RoleCommitteeRapporteurShadows
Opinion ENVI ANTONESCU Elena Oana (EPP)
Lead LIBE PROTASIEWICZ Jacek (EPP) HEDH Anna (S&D), WEBER Renate (ALDE), SCHLYTER Carl (Verts/ALE), KIRKHOPE Timothy (ECR), TRIANTAPHYLLIDES Kyriacos (GUE/NGL)
Lead committee dossier: LIBE/7/13824
Legal Basis TFEU 114

Activites

  • 2014/04/17 Vote in plenary scheduled
  • 2014/03/13 Committee report tabled for plenary, 1st reading/single reading
    • A7-0172/2014 summary
  • 2014/03/10 Vote in committee, 1st reading/single reading
  • #3290
  • 2014/01/28 Council Meeting
  • 2013/10/08 Committee referral announced in Parliament, 1st reading/single reading
  • #3260
  • 2013/10/07 Council Meeting
  • 2013/09/17 Legislative proposal published
    • COM(2013)0619 summary
    • DG {'url': 'http://ec.europa.eu/justice/', 'title': 'Justice'}, REDING Viviane

Documents

  • Legislative proposal published: COM(2013)0619
  • Debate in Council: 3290
  • Committee report tabled for plenary, 1st reading/single reading: A7-0172/2014
AmendmentsDossier
148 2013/0305(COD)
2014/01/10 ENVI 43 amendments...
source: PE-526.242
2014/01/29 LIBE 105 amendments...
source: PE-519.808

History

(these mark the time of scraping, not the official date of the change)

activities/3/docs
  • url: http://register.consilium.europa.eu/content/out?lang=EN&typ=SET&i=SMPL&ROWSPP=25&RESULTSET=1&NRROWS=500&DOC_LANCD=EN&ORDERBY=DOC_DATE+DESC&CONTENTS=3290*&MEET_DATE=28/01/2014 type: Debate in Council title: 3290
activities/3/docs
  • url: http://register.consilium.europa.eu/content/out?lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014 type: Debate in Council title: 3290
activities/5/docs/0/text
  • The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Jacek PROTASIEWICZ (EPP, PL) on the proposal for a regulation of the European Parliament and of the Council on new psychoactive substances.

    The committee recommended that Parliament’s position in first reading following the ordinary legislative procedure should amend the Commission position as follows:

    Information exchange: to enable a more effective response to the rapid emergence and spread of new psychoactive substances across the Union, Members considered that the information exchange mechanism (the 'Early Warning System') should be maintained and further developed, in particular as regards to the collection and management of data on the detection and identification of new psychoactive substances.

    The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) should issue health alerts to all Member States, through the system for rapid exchange of information on new psychoactive substances if, on the basis of information received on a new psychoactive substances, this seemed to cause public health concerns. Those health alerts should also contain information regarding prevention, treatment and harm reduction measures that could be taken to address the risk of the substance.

    Immediate risks to public health, and market restrictions: the proposal provided that the Commission should, by means of a Decision, prohibit the making available on the market to consumers of the new psychoactive substance if, based on existing information, it poses immediate risks to public health. The market restriction should not exceed a period of twelve months.

    Members proposed that if the level of health, social and safety risks posed by the new psychoactive substance justified the introduction of permanent restriction measures, the duration of the temporary market restriction may be extended by a further 12 months, in the absence of permanent market restriction.

    Low risks at Union level: the Commission should not adopt restriction measures on a new psychoactive substance if, based on the existing evidence and on prescribed criteria, it posed, overall, low health, social and safety risks at Union level.

    However, where the decision to not adopt restriction measures on a new psychoactive substance that was considered to pose overall low health, social and safety risk at Union level was based on a partial or total lack of evidence, it should include an appropriate reference in the justification.

    The report also stressed that Members States should not be prohibited from introducing or maintaining the more stringent measures regarding the specific risks the new psychoactive substance posed within their territory, independently of the classification of the substance by the Commission as posing low or moderate risks on the EU level. The relevant laws, regulations or administrative provisions should be communicated to the Commission and the other Member States should be informed.

    Authorised use: decisions prohibiting the marketing of new psychoactive substance presenting a serious risk should not impede the free movement in the Union and the production, manufacture, making available on the market of new psychoactive substances for scientific research and development purposes, by duly authorised persons in establishments which were directly under the control of Member States' authorities or specifically approved by them.

    For all of authorised uses, new psychoactive substances and products containing new psychoactive substances should include directions for use, including cautions, warnings and contraindications with other substances, to be either indicated on the label or included in the accompanying leaflet for the safety of the user.

    Furthermore, Member States should take any appropriate measures to prevent the diversion to the illicit market of new psychoactive substances used for research and development purposes or for any other authorised uses.

    Research, analysis, prevention and funding: the amended text provided that financial support and the necessary resources should be provided at Union and national level for the development, sharing and dissemination of information and knowledge on new psychoactive substances. 

    Moreover, the Commission and the Member States should promote the research into new psychoactive substances and ensure cooperation and coordination between networks at national and Union level in order to strengthen understanding of the phenomenon. 

    Prevention schemes as well as measures to raise awareness of the risks posed by psychoactive substances, such as educational information campaigns should be promoted.

    Evaluation: five years after the entry into force of the Regulation and every five years thereafter, the Commission should:

    • assess the implementation, application and effectiveness of this Regulation and publish a report. In this respect, the Commission, the EMCDDA and Europol should conduct post-risk assessments of new psychoactive substances;
    • evaluate and if appropriate present a proposal for possible classification of groups of the new psychoactive substances in order to counteract the practise of bypassing the legislation in force by slight modifications of the chemical structure of the psychoactive substances.
activities/0/docs/0/url
Old
http://old.eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
New
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
activities/5/docs
  • url: http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A7-2014-0172&language=EN type: Committee report tabled for plenary, 1st reading/single reading title: A7-0172/2014
activities/6/date
Old
2014-04-15T00:00:00
New
2014-04-17T00:00:00
activities/6/type
Old
Indicative plenary sitting date, 1st reading/single reading
New
Vote in plenary scheduled
activities/0/docs/0/url
Old
http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
New
http://old.eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619
activities/3/docs/0/url
Old
http://www.europarl.europa.eu/ http://register.consilium.europa.eu/servlet/driver?page=Result&typ=Simple&cmsid=638&ff_COTE_DOCUMENT=&ff_TITRE=&ff_SOUS_COTE_MATIERE=&fc=REGAISEN&srm=25&md=400&ssf=DATE_DOCUMENT+DESC&single_comparator=%3D&from_date=&to_date=&lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014
New
http://register.consilium.europa.eu/content/out?lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014
activities/4
date
2014-03-10T00:00:00
body
EP
type
Vote in committee, 1st reading/single reading
committees
activities/5
date
2014-03-13T00:00:00
body
EP
type
Committee report tabled for plenary, 1st reading/single reading
committees
procedure/stage_reached
Old
Awaiting committee decision
New
Awaiting Parliament 1st reading / single reading / budget 1st stage
activities/4/date
Old
2014-04-03T00:00:00
New
2014-04-15T00:00:00
activities/4/date
Old
2014-04-17T00:00:00
New
2014-04-03T00:00:00
activities/4/date
Old
2014-04-15T00:00:00
New
2014-04-17T00:00:00
activities/3
body
CSL
meeting_id
3290
docs
url: http://www.europarl.europa.eu/ http://register.consilium.europa.eu/servlet/driver?page=Result&typ=Simple&cmsid=638&ff_COTE_DOCUMENT=&ff_TITRE=&ff_SOUS_COTE_MATIERE=&fc=REGAISEN&srm=25&md=400&ssf=DATE_DOCUMENT+DESC&single_comparator=%3D&from_date=&to_date=&lang=EN&ff_FT_TEXT=3290&dd_DATE_REUNION=28/01/2014&single_date=28/01/2014 type: Debate in Council title: 3290
council
Economic and Financial Affairs ECOFIN
date
2014-01-28T00:00:00
type
Council Meeting
other/0
body
CSL
type
Council Meeting
council
Former Council configuration
activities/0/docs/1
url
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2013:0319:FIN:EN:PDF
type
Document attached to the procedure
title
SWD(2013)0319
activities/0/docs/2
url
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2013:0320:FIN:EN:PDF
type
Document attached to the procedure
title
SWD(2013)0320
activities/0/type
Old
Legislative proposal
New
Legislative proposal published
activities/3
date
2013-12-23T00:00:00
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE519.611 type: Committee draft report title: PE519.611
body
EP
type
Committee draft report
activities/4/date
Old
2014-03-11T00:00:00
New
2014-04-15T00:00:00
activities/3/docs/0/url
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE519.611
activities/3
date
2013-12-23T00:00:00
docs
type: Committee draft report title: PE519.611
body
EP
type
Committee draft report
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
activities/0/docs/0/celexid
CELEX:52013PC0619:EN
activities/3
date
2014-03-11T00:00:00
body
EP
type
Indicative plenary sitting date, 1st reading/single reading
activities/2/committees/1/shadows/2
group
Verts/ALE
name
SCHLYTER Carl
committees/1/shadows/2
group
Verts/ALE
name
SCHLYTER Carl
activities/2/committees/1/shadows/1
group
ALDE
name
WEBER Renate
committees/1/shadows/1
group
ALDE
name
WEBER Renate
procedure/summary
  • See also
activities/2/committees/1/shadows/0
group
S&D
name
HEDH Anna
committees/1/shadows/0
group
S&D
name
HEDH Anna
links/National parliaments
url
http://www.ipex.eu/IPEXL-WEB/dossier/dossier.do?code=COD&year=2013&number=0305&appLng=EN
title
IPEX
activities/2/committees/1/shadows
  • group: ECR name: KIRKHOPE Timothy
  • group: GUE/NGL name: TRIANTAPHYLLIDES Kyriacos
committees/1/shadows
  • group: ECR name: KIRKHOPE Timothy
  • group: GUE/NGL name: TRIANTAPHYLLIDES Kyriacos
procedure/summary
  • See also
procedure/summary
  • See also
activities/0/docs/0/text
  • PURPOSE: to approximate the rules relating to new psychoactive substances that are of concern at Union level whilst ensuring a high level of health, safety and consumer protection.

    PROPOSED ACT: Regulation of the European Parliament and of the Council.

    ROLE OF THE EUROPEAN PARLIAMENT: the European Parliament decides in accordance with the ordinary legislative procedure and on an equal footing with the Council.

    BACKGROUND: new psychoactive substances, which may have numerous commercial and industrial uses, as well as scientific uses, can pose health, social and safety risks when consumed by humans. Consumption of new psychoactive substances appears to be increasing in Europe and use is predominant among young people. According to the 2011 Eurobarometer "Youth attitudes on drugs", 5% of young people in the EU have used such substances at least once in their life, with a peak of 16% in Ireland, and close to 10% in Poland, Latvia and the UK.

    During the past years, Member States have notified an increasing number of new psychoactive substances to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). National restriction measures, which can vary depending on the Member State and on the substance, lead to obstacles to trade in licit uses, fragmentation, an uneven level playing field and legal uncertainties for economic operators, and make it difficult for companies to operate across the internal market. They make research more cumbersome, hampering the development of new uses for these substances.

    In this context, the case for swifter, more effective and more proportionate action on new psychoactive substances at EU level is compelling, considering the rapid changes in this market, which put national authorities under pressure to act.

    The Commission Communication "Towards a stronger European response to drugs", adopted in October 2011, identified the spread of new psychoactive substances as one of the most challenging developments in drugs policy requiring a firmer EU response.

    IMPACT ASSESSMENT: taking into account the results of impact assessment, the following solutions are preferred: (i) a more graduated and better targeted set of restriction measures on new psychoactive substances, which should not hinder the industrial use of substances; (ii) restriction measures should be introduced earlier; (iii) substances suspected to pose immediate public health risks should be subjected to temporary restrictions; (iv) restriction measures should be proportionate to a better determined level of risk of substances; (v) restriction measures should be introduced through a quicker procedure.

    LEGAL BASIS: Article 114 of the Treaty on the Functioning of the European Union.

    CONTENT: this proposed Regulation – which is intended to replace Council Decision 2005/387/JHA - aims at ensuring that trade in new psychoactive substances having industrial and commercial uses is not hindered and that the functioning of this market is improved, while the health and safety of individuals are protected from harmful substances, which cause concern at the EU level.

    The proposal is accompanied by a proposal for a Directive amending Council Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

    The main elements of the proposal are as follows:

    Exchange of information and temporary consumer market restrictions: this proposal sets up a robust system: (i) for exchanging rapidly information on new psychoactive substances emerging on the market, including on their commercial and industrial uses, for assessing the risks of substances that cause EU-wide concern and; (ii) for withdrawing from the market those substances that pose risks.

    The substances suspected to pose immediate public health risk will be withdrawn from the consumer market temporarily, pending their risk assessment. Once the risk assessment is completed, measures will be taken proportionate to the risks of substances.

    The proposal establishes the respective roles of Member States, the EMCDDA and Europol in the process of exchange of information on new psychoactive substances.

    Low and moderate risks: according to the proposal, no restriction measures shall be introduced on new psychoactive substances posing low health, social and safety risks and provides a definition of low risks.

    For substances posing moderate risks and permanent consumer market restrictions, they cannot be sold to consumers (except for uses specifically authorised, for instance by medicines legislation) but their trade is allowed for commercial and industrial purposes as well as for scientific research and development.

    Severe risks: the proposal empowers the Commission to prohibit the production, manufacture, making available on the market, transport, importation or exportation of new psychoactive substances which pose severe health, social and safety risks, and provides a definition of severe risks.

    New psychoactive substances posing severe risks will be subjected to permanent market restriction, covering both the consumer and commercial markets, and their use will only be possible for specifically authorised industrial and commercial purposes, as well as for scientific research and development. In addition, these substances will be subjected to EU criminal law provisions.

    Sanctions: the proposal establishes the obligation for the Member States to lay down the rules on administrative sanctions applicable to infringements to market restriction, and to ensure that they are effective, proportionate and dissuasive.

    BUDGETARY IMPLICATION: the proposal has no direct impact on the EU budget and does not create new tasks for the EMCDDA, Europol, the European Medicines Agencies, the European Chemicals Agency (ECHA) and the European Food Safety Authority (EFSA).

activities/2/committees/0/date
2013-10-10T00:00:00
activities/2/committees/0/rapporteur
  • group: EPP name: ANTONESCU Elena Oana
committees/0/date
2013-10-10T00:00:00
committees/0/rapporteur
  • group: EPP name: ANTONESCU Elena Oana
activities/2
date
2013-10-08T00:00:00
body
EP
type
Committee referral announced in Parliament, 1st reading/single reading
committees
procedure/dossier_of_the_committee
LIBE/7/13824
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision
activities/1
date
2013-10-07T00:00:00
body
CSL
type
Council Meeting
council
Justice and Home Affairs (JHA)
meeting_id
3260
procedure/Mandatory consultation of other institutions
Economic and Social Committee
activities
  • date: 2013-09-17T00:00:00 docs: url: http://eur-lex.europa.eu/smartapi/cgi/sga_doc?smartapi!celexplus!prod!DocNumber&lg=EN&type_doc=COMfinal&an_doc=2013&nu_doc=619 celexid: CELEX:52013PC0619:EN type: Legislative proposal published title: COM(2013)0619 url: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2013:0319:FIN:EN:PDF type: Document attached to the procedure title: SWD(2013)0319 url: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2013:0320:FIN:EN:PDF type: Document attached to the procedure title: SWD(2013)0320 body: EC type: Legislative proposal commission: DG: url: http://ec.europa.eu/justice/ title: Justice Commissioner: REDING Viviane
committees
  • body: EP responsible: False committee_full: Environment, Public Health and Food Safety committee: ENVI
  • body: EP responsible: True committee: LIBE date: 2013-09-30T00:00:00 committee_full: Civil Liberties, Justice and Home Affairs rapporteur: group: EPP name: PROTASIEWICZ Jacek
links
European Commission
other
  • body: EC dg: url: http://ec.europa.eu/justice/ title: Justice commissioner: REDING Viviane
procedure
reference
2013/0305(COD)
title
New psychoactive substances
legal_basis
Treaty on the Functioning of the EU TFEU 114
stage_reached
Preparatory phase in Parliament
subtype
Legislation
instrument
Regulation
type
COD - Ordinary legislative procedure (ex-codecision procedure)
subject